Clasp Therapeutics aims to bring absolute precision to immuno-oncology by developing next-generation T cell engagers (TCEs) that target tumor-specific oncogenic driver mutations across hard-to-treat cancers. Clasp is developing T cell engagers to match both the specific characteristics of the patien... Read more
This company has no offices yet
City Therapeutics
1 follower
Avenzo Therapeutics
1 follower
Daiichi Sankyo (Switzerland)
2 followers
Montara Therapeutics, Inc.
1 follower
Procella Therapeutics
2 followers
SelectScience®
1 follower
ARS Pharmaceuticals
2 followers
The DRIPBaR
2 followers
DataXight
2 followers
Vantive
12 followers
iGEM
1 follower
Isomorphic Labs
18 followers